Tsuji A, Terasaki T, Takabatake Y, Tenda Y, Tamai I, Yamashima T, Moritani S, Tsuruo T, Yamashita J
Faculty of Pharmaceutical Sciences, Kanazawa University, Japan.
Life Sci. 1992;51(18):1427-37. doi: 10.1016/0024-3205(92)90537-y.
The expression of a functional P-glycoprotein (P-gp) which pumps drugs out of brain capillary endothelial cells (BCEC) into blood was studied by evaluating the steady-state uptake and efflux of vincristine (VCR) by primary cultured bovine BCEC. The steady-state uptake of VCR was increased in the presence of metabolic inhibitors, and an anti-P-gp monoclonal antibody, MRK16, as well as verapamil and steroid hormones which are known to reverse multidrug resistance in tumor cells. Furthermore, efflux of VCR from BCEC was inhibited by verapamil. By immunohistochemistry, P-gp was localized at the luminal side of the capillary endothelial cells in both gray matter of bovine brain and primary cultured BCEC. These data suggest that P-gp functions as a drug efflux pump at the luminal side of BCEC and regulates the transfer of certain lipophilic drugs from the blood into the brain.
通过评估原代培养的牛脑毛细血管内皮细胞(BCEC)对长春新碱(VCR)的稳态摄取和外排,研究了一种将药物从脑毛细血管内皮细胞泵入血液的功能性P-糖蛋白(P-gp)的表达。在存在代谢抑制剂、抗P-gp单克隆抗体MRK16以及已知可逆转肿瘤细胞多药耐药性的维拉帕米和甾体激素的情况下,VCR的稳态摄取增加。此外,维拉帕米抑制了VCR从BCEC的外排。通过免疫组织化学,P-gp定位于牛脑灰质和原代培养的BCEC中毛细血管内皮细胞的腔面。这些数据表明,P-gp在BCEC的腔面作为药物外排泵发挥作用,并调节某些亲脂性药物从血液向脑内的转运。